arrow
L

Luciano Giacò

uos
H指数:12
被引数:559

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Human amniotic mesenchymal stromal cell-derived extracellular vesicles reprogram microglia and prevent neurodegeneration in experimental models of Alzheimer’s disease

人羊膜间充质基质细胞来源的细胞外囊泡重编程小胶质细胞并预防阿尔茨海默病实验模型中的神经退行性変

2026-09-090
OAAI
Spatial organization of the tumor immune microenvironment in LAR+ triple-negative breast cancer

LAR+三阴性乳腺癌肿瘤免疫微环境的空间组织

2026-05-220
OAAI
Enhanced Detection of BRCA Copy Number Alterations Within a Commercial HRD Assay: Implications for Precision Oncology in Ovarian Cancer

BRCA拷贝数改变在商业HRD检测中的增强检测:对卵巢癌精准肿瘤学的意义

2026-04-290
OAAI
RNA cargo profiling of muscle extracellular vesicles identifies candidate biomarkers of disease activity and muscle degeneration in FSHD

肌肉外泌体RNA载荷谱分析确定了FSHD疾病活动性和肌肉退行性变的候选生物标志物

2026-02-250
OAAI
Concordance Analysis of Microsatellite Instability via NGS and Mismatch Repair Deficiency via IHC in Endometrial and Colorectal Cancer

通过NGS进行微卫星不稳定性分析及通过IHC进行错配修复缺陷分析在子宫内膜癌和结直肠癌中的应用

2026-02-250
OAAI
Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers

破译上皮性卵巢癌的脑转移: 多模态分析和潜在的生物标志物

2026-01-190
OAAI
Detection of Clinically Significant BRCA Large Genomic Rearrangements in FFPE Ovarian Cancer Samples: A Comparative NGS Study

临床意义显著BRCA大基因组重排的检测:一项比较NGS研究(在FFPE卵巢癌样本中)

2025-10-010
OAAI
Oncological Treatment Adverse Reaction Prediction: Development and Initial Validation of a Pharmacogenetic Model in Non-Small-Cell Lung Cancer Patients

肿瘤治疗不良反应预测:非小细胞肺癌患者中药物基因组学模型的开发与初步验证

GENES
IF2.8
2025-02-240
OA
Assessment Of The Predictive Role Of Khorana Score And Genomic Profiling In Ovarian Cancer-Related Venous Thromboembolism

评估Khorana评分和基因组分析在卵巢癌相关静脉血栓栓塞中的预测作用

2025-02-010
PRE
Deep Dive Into No Specific Molecular Profile (NSMP) Endometrial Cancer: Unraveling Genomic Features According To Estrogen Receptor (ER) Expression

深入探讨无特定分子谱(NSMP)子宫内膜癌:根据雌激素受体(ER)表达解析基因组特征

2025-02-010
PRE
Comprehensive Genomic Profiling (CGP) In Epithelial Ovarian Cancer: Biomarker Prevalence Across Different Histotypes

上皮性卵巢癌中的综合基因组分析(CG P):不同组织学类型的生物标志物流行率

2025-02-010
PRE
POLE mutations in endometrial carcinoma: Clinical and genomic landscape from a large prospective single-center cohort

子宫内膜癌中的POLE突变:来自大型前瞻性单中心队列的临床与基因组特征

CANCER
IF5.1
2025-01-250
OAAI
A monocentric analysis of ESCAT gene actionability detection in non-specific molecular profile (NSMP) early-stage endometrial cancer

非特异性分子表型(NSMP)早期子宫内膜癌中ESCAT基因可操作性的单中心分析

2024-09-010
PRE
Homologous recombination (HR) and DNA damage repair (DDR) somatic alterations in metastatic colorectal cancer (mCRC): Results from the comprehensive genomic profiling (CGP) trial FPG500

同源重组(HR)和DNA损伤修复(DDR)体细胞改变在转移性结直肠癌(mCRC)中的研究:综合基因组分析(CGP)试验FPG500的结果

2024-09-010
PRE